Schroder Investment Management Group
VTYX

Schroder Investment Management Group’s Ventyx Biosciences VTYX Stock Holding History

Schroder Investment Management Group’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-15,000
Closed -$37K – 1251
2023
Q4 		$37K Buy
+15,000
New +$142K ﹤0.01% 1177

Other funds holding VTYX

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Schroder Investment Management Group's VTYX Position: Q1 2024 in Review

Schroder Investment Management Group sold out of Ventyx Biosciences (VTYX) in Q1 2024, closing a stake of 15,000 shares — an estimated $37K sold.

Schroder Investment Management Group first reported a position in VTYX in Q4 2023 and held it in 1 quarter. The position peaked at $37K in Q4 2023. 126 funds tracked by Wall St. Rank hold VTYX as of Q1 2024.

  • Schroder Investment Management Group reported no remaining Ventyx Biosciences position as of Q1 2024 after selling out during the quarter.
  • Schroder Investment Management Group sold 15,000 Ventyx Biosciences shares in Q1 2024, an estimated $37K.
  • Schroder Investment Management Group first reported a position in Ventyx Biosciences in Q4 2023 and held it in 1 quarter.
  • Schroder Investment Management Group's Ventyx Biosciences position peaked at $37K in Q4 2023.
  • 126 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2024.

Based on Schroder Investment Management Group's 13F filing for Q1 2024, filed 14 May 2024.